Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients

Objectives: Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to predict the severity and mortality of COVID-19. Methods: Serum ACE2 activity was measured in COVID-19 (110 critically ill an...

Descripción completa

Detalles Bibliográficos

Autores principales:	Miklós Fagyas, Zsolt Fejes, Renáta Sütő, Zsuzsanna Nagy, Borbála Székely, Marianna Pócsi, Gergely Ivády, Edina Bíró, Gabriella Bekő, Attila Nagy, György Kerekes, Zoltán Szentkereszty, Zoltán Papp, Attila Tóth, János Kappelmayer, Béla Nagy, Jr.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2022-02-01
Colección:	International Journal of Infectious Diseases
Materias:	SARS-CoV-2 ACE2 inflammation COVID-19 disease biomarker outcome
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S1201971221008766
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!